Email updates

Keep up to date with the latest news and content from BMC Research Notes and BioMed Central.

Open Access Research article

Daily versus intermittent iron supplementation in pregnant women

Zinatossadat Bouzari12, Zahra Basirat3, Mahtab Zeinal Zadeh3, Shahla Yazdani Cherati3, Maryam Didehdar Ardebil45, Maedeh Mohammadnetaj6 and Shahnaz Barat7*

Author Affiliations

1 Department of Obstruction & Gynecology, Babol University of Medical Science, Babol, Iran

2 Stem Cell Research Center, Babol University of Medical Science, Babol, Iran

3 Department of Obstruction & Gynecology, Babol University of Medical Science, Babol, Iran

4 Azad Islamic University, Sarab, Iran

5 Department of Psychology, Panjab University, India

6 Mazandaran University, Iran

7 Department of Obstruction & Gynecology, Babol University of Medical Science, Babol, Iran

For all author emails, please log on.

BMC Research Notes 2011, 4:444  doi:10.1186/1756-0500-4-444

Published: 25 October 2011

Abstract

Background

The purpose of this study was compare of daily iron supplementation in three time frames- daily, weekly and three time weekly supplementation in preventing anemia in healthy pregnant women.

Method

The present study was a prospective simply randomized clinical trial. During January 2006- January 2008, 150 healthy pregnant women without anemia, in their 16th week of pregnancy were randomly allocated into three equal groups. The first group (n = 50) received a 50 mg-ferrous sulfate tablet daily, second group (n = 50) received a 50 mg-ferrous sulfate tablet three times a week, and the third group (n = 50) received two 50 mg-ferrous sulfate tablets (100 mg) weekly, respectively for 12 consecutive weeks. Serum hemoglobin, ferritin, and iron were measured before and after the supplementation. Paired t and ANOVA tests were used as appropriated.

Results

There were no significant differences between the pre- and post-treatment hemoglobin levels with iron supplementation in the three group (P = 0.518, P = 0.276, respectively). The mean serum iron level before and after treatment with iron supplementation in the three groups was not statistically significant (P = 0.962, P = 0.970, respectively). Although the mean serum ferritin level before and after treatment with iron supplementation was statistically significant in the three groups, no significant differences were found comparing the three groups (P = 0.827, P = 0.635 respectively).

Conclusions

This results suggested, three times a week or weekly iron supplementation is as effective as daily supplementation for healthy pregnant women without anemia.

Trial Registration

ISRCTN: IRCT201101093820N1